Stone Crest Wealth Management, Inc. Argenx Se Transaction History
Stone Crest Wealth Management, Inc.
- $248 Billion
- Q4 2025
A detailed history of Stone Crest Wealth Management, Inc. transactions in Argenx Se stock. As of the latest transaction made, Stone Crest Wealth Management, Inc. holds 730 shares of ARGX stock, worth $662,825. This represents 0.25% of its overall portfolio holdings.
Number of Shares
730
Previous 730
-0.0%
Holding current value
$662,825
Previous $538 Million
14.02%
% of portfolio
0.25%
Previous 0.24%
Shares
6 transactions
Others Institutions Holding ARGX
# of Institutions
536Shares Held
26MCall Options Held
589KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...